Bookmark and Share

This article is in the news archive.

Professor Barbara Sahakian discusses the future of drug development for Mental Illness

In any given year, nearly 40% of the population in 30 European countries is affected by Mental Illness. In a Comment article in Nature on March 15th, Professor Barbara Sahakian and Thomas Insel describe what the next decade of drug development should look like.

Professor Barbara J. Sahakian is in the Department of Psychiatry and MRC/Wellcome Trust Behavioural and Clinical Neuroscience Institute.

Posted on 26/03/2012

Further news

Go to the news index page.